Sep 27, 2021 / 04:10PM GMT
Louise Alesandra Chen - Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
Good day. I'm Louise Chen, the large-cap and biopharma analyst here at Cantor. Before we begin, I wanted to turn the presentation over to Chris Stevo in Investor Relations to make some forward-looking statements.
Christopher J. Stevo - Pfizer Inc. - Senior VP & Chief IR Officer
Thank you, Louise. Just a quick reminder that we'll be making forward-looking statements and forward-looking commentary as well. And as you're all familiar, actual results could be different than these. Additional information regarding forward-looking statements is available under risk factors and forward-looking information and factors that may affect future results in our SEC filings, on Form 10-K and 10-Q. Thank you.
Louise Alesandra Chen - Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
Thank you very much, Chris. And now I'd like to introduce Albert Bourla, our keynote speaker and the CEO of Pfizer.
Pfizer Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 27, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers